UK firms hail victory in battle over COVID-19 insurance claims

LONDON (Reuters) – London judges have ruled that some of the world’s biggest insurers were wrong to reject tens of thousands of claims from small firms battered by the COVID-19 pandemic, Britain’s Financial Conduct Authority (FCA) said on Tuesday.

FILE PHOTO: A pedestrian walks past skyscrapers in the financial district in London, Britain February 17, 2020. REUTERS/Simon Dawson

The FCA, which brought the test case against eight insurers, said the court had found in favour of policyholders’ arguments on the majority of key issues in a complex, 162-page judgment.

However, some of the insurers said the ruling meant they wouldn’t have to pay out, or would have to pay out much less than modelled in a worse-case scenario, and Britain’s Federation of Small Businesses called the judgment a “partial” victory.

The lawsuit has been closely watched because it is estimated to affect 370,000 businesses and

Read More

Continue Reading

‘Tacos & Tastemakers’ finds musicians retracing their creative paths at Twin Cities taquerias

For most of the past year, Elabbady dreamed and schemed, then assembled a crew to bring to life his brand new show, intended to one day find its way to television. He’s called it Tacos & Tastemakers.

The idea for his show first bubbled into Elabbady’s mind after the loss of Anthony Bourdain. “I wanted to bring back the element of conversation he was able to strike up with musicians and music adjacent people, as well as cast a wider net to third culture kids like me,” he tells City Pages.

Its creator describes the project as the intersection of Parts Unknown and Comedians in Cars Getting Coffee… plus tacos. 

As he began to flesh out the show’s format, our host – who has lovingly written about one particular form of tacos for this very publication! – explained, “Tacos seemed to be more of a natural fit than anything

Read More

Continue Reading

LB Pharmaceuticals Inc Announces Results of LB-102 Phase 1 First-in-Human Clinical Study

  • Phase 1 clinical trial evaluated multiple doses of LB-102 (N-methyl amisulpride) in 64 healthy adults ages 18-55 years
  • LB-102 was safe and well-tolerated and displayed dose linear PK
  • Phase 2 clinical study in schizophrenia patients planned for mid- 2021; retains Mizuho Securities as exclusive financial advisor

LB Pharmaceuticals Inc, (“LB”, or the “Company”), a biotechnology company focused on developing and commercializing novel and improved versions of successful CNS treatments, today announced the results of a Phase 1 clinical study of LB-102 (NCT04187560), a novel derivative of amisulpride designed to treat schizophrenia. Data from this study were presented at the 33rd annual meeting of the European College of Neuropsychopharmacology (ECNP), which is being held virtually. A copy of the Company’s poster can be viewed online at http://lbpharma.us/presentations/

This was a combined single ascending dose (SAD)/multiple ascending dose (MAD) study with safety as the primary endpoint and PK as a

Read More

Continue Reading

Insights on the Fiber Optic Global Market to 2027 – by Type, Data Rate & Application

The “Fiber Optic Components Market Forecast to 2027 – COVID-19 Impact and Global Analysis by Type, Amplifiers, Splitters, Connectors, Circulators, Transceivers, and Others); Data Rate; Application” report has been added to ResearchAndMarkets.com’s offering.

According to this report the market was valued at US$ 16,546.7 million in 2019 and is projected to reach US$ 39,150.3 million by 2027; it is expected to grow at a CAGR of 11.27% from 2020 to 2027.

Asia Pacific dominated the fiber optic components Market in 2019 with a share of 35.8% followed by North America. The fiber optic components market in APAC is analyzed based on historical, current, and future trends across the region. The fiber optic components market in APAC is further segmented into China, India, Japan, South Korea, Australia, and the Rest of APAC. The adoption of fiber optics is high in this region owing to development in the communications applications; thus, the

Read More

Continue Reading

Alphabet Stock is a Play on Economic Recovery as Advertising Picks Up

InvestorPlace – Stock Market News, Stock Advice & Trading Tips

Alphabet (NASDAQ:GOOG, NASDAQ:GOOGL) stock is up almost 13% year-to-date even after the recent market decline. In fact, the stock is up almost 25% in the past year, but most of that increase has come in the past six months.

Google Stock Is a Top Blood-in-the -Street Opportunity

Source: Valeriya Zankovych / Shutterstock.com

The market anticipates that an economic recovery is coming and this will boost Google’s basic digital advertising business. This will continue to boost Alphabet stock higher, as I pointed out in my last article in August, as well as my May article.

Moreover as the economy grows, the demand for advertising picks up. This leads to a positive feedback loop, since there are many direct and indirect effects that advertising plays in the economy.

Advertising Drives Alphabet Stock

Keep in mind that 78% of Alphabet’s revenue, as of the latest quarter (see

Read More

Continue Reading

The world’s biggest financial bailouts



Microsoft may earn an Affiliate Commission if you purchase something through recommended links in this article


At the epicenter of the 2008 financial crisis was the collapse of the Lehman Brothers bank, which filed for bankruptcy on September 15, 2008, leaving a debt of more than US$600 billion behind.



Microsoft may earn an Affiliate Commission if you purchase something through recommended links in this article


Then-president George W. Bush was forced to pass the Emergency Economic Stabilization Act of 2008, which authorized the United States Secretary of the Treasury to spend up to US$700 billion to save banks and the economy.



Microsoft may earn

Read More

Continue Reading

NK Cell Therapy Market Size is set to record 15.5% CAGR during forecast 2025

The MarketWatch News Department was not involved in the creation of this content.

Sep 16, 2020 (Market Insight Reports) —
Selbyville, Delaware Growth forecast report ” NK Cell Therapy Market size by Product Type (NK Cell Therapies and NK Cell Directed Antibodies), By Application (Cancer, Gastrointestinal Diseases and Others), By Region Outlook (North America, Europe, Asia-Pacific, South America & Middle East and Africa), Top Manufacturer, Growth Potential, Price Trends, Competitive Market Share & Forecast 2020-2025 added by Market Study Report LLC.

The global NK Cell Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 15.5%% in the forecast period of 2020 to 2025 and will expected to reach USD 466.5 million by 2025, from USD 262.1 million in 2019.

Request a sample Report of NK Cell Therapy Market at: https://www.marketstudyreport.com/request-a-sample/2915618?utm_source=Marketwatch.com&utm_medium=AN

The NK Cell Therapy market stands tall as

Read More

Continue Reading

Cloud Based Payroll Software Market 2020: Rising Impressive Business Opportunities Analysis Forecast By 2027

The MarketWatch News Department was not involved in the creation of this content.

Sep 15, 2020 (AmericaNewsHour) —
Cost-effectiveness in deployment and up-gradation with the latest anti-virus protection along with system improvements will steer the market expansion over the forecast timeline. In addition to this, cloud-based payroll software also informs the users about their compliance status as well as changes in the regulations or rules of the firm. It also helps the firms provide the staff the access to their own information on the web portal. Nonetheless, growing concerns over security as well as the confidentiality of the employee data can pose a threat to the growth of the market over the forecast period.

The report covers the forecast and analysis of the cloud based payroll software market on a global and regional level. The study provides historical data from 2015 to 2018 along with a forecast from 2019 to

Read More

Continue Reading

First Horizon National Corp. to Participate at Barclays Global Financial Services Conference

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

MEMPHIS, Tenn., Sept. 08, 2020 (GLOBE NEWSWIRE) — Bryan Jordan, president and CEO of First Horizon National Corporation (NYSE:FHN), will participate in a virtual fireside chat at the Barclays Global Financial Services Conference on September 14, 2020 at 3:30 p.m. Eastern Time.

The fireside chat will be available to the public via live webcast with audio replays available for 14 days after the conference. A link to the webcast, both live and archived, along with the materials for this conference will be available in the events and presentations section of http://ir.fhnc.com.

The presentation and any related materials may contain forward-looking statements, including guidance, involving significant risks and uncertainties, which will be identified by words such as “believe,” “expect,” “anticipate,” “intend,” “estimate,” “should,” “is likely,” “will,” “going forward” and

Read More

Continue Reading

Minda Industries shares gain 3% on raising Rs 242 crore via rights issue



Minda Industries shares gain 3% on raising Rs 242 crore via rights issue


© PTI
Minda Industries shares gain 3% on raising Rs 242 crore via rights issue

Minda Industries share price gained over 3 percent intraday on September 15 after the company raises over Rs 242 crore through rights issue.

The auto components maker said it has raised over Rs 242 crore by way of a rights issue to existing investors. On June 29, the board of directors of Minda Industries approved the issuance of equity shares by way of a rights issue to eligible equity shareholders of the company for an aggregate amount not exceeding Rs 250 crore.

“The rights issue committee of the board of company have… considered and approved the allotment of 97,11,739 equity shares of face value Rs 2 each to the eligible applicants in the rights issue at an issue price of Rs 250 per equity share (including a premium of Rs 248 per equity share),” Minda

Read More

Continue Reading

Load More